Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

Caitlin E. Cox

August 01, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Shelley Wood

July 12, 2021

News Daily News

Paper Probes Physical Activity Paradox and Perils of ‘Privileged’ Advice

Shelley Wood

April 15, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Todd Neale

May 06, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

Yael L. Maxwell

April 24, 2019

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Daily News

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Michael O'Riordan

June 09, 2017

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

Advertisement

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Paper Probes Physical Activity Paradox and Perils of ‘Privileged’ Advice

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

TCTMD’s Top 10 Most Popular Stories for June 2017

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Statins Reduce Late Restenosis After SES Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content